Position in ABBV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$9,506,959
+$1,990,940 QoQ
Shares Held
37,780
+9.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.28%
of 13F equity value
Holder Rank
#945
of 4,152 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Vanguard National Trust Co holds $25,698,771 across 14 Drug Manufacturers - General names. ABBV ranks #1 (37.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
37,780 | $9,506,959 | |
| 2 | LLY |
ELI LILLY & Co
|
4,977 | $5,969,563 | |
| 3 | JNJ |
Johnson & Johnson
|
23,246 | $5,903,786 | |
| 4 | MRK |
Merck & Co., Inc.
|
13,832 | $1,777,412 | |
| 5 | AMGN |
Amgen Inc
|
4,293 | $1,554,581 | |
| 6 | PFE |
Pfizer Inc
|
12,807 | $308,392 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,337 | $295,256 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
2,369 | $136,501 |
All Filings in ABBV
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,506,959 | 37,780 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $7,516,019 | 34,558 | Shares | Defined | 2026-05-08 | |
| No filing history on record for this holder in this stock. | ||||||